Mass drug administration targeting Onchocerca volvulus in Owabi catchment area in Ashanti Region, Ghana: Determinants of drug coverage and drug uptake.
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Mass drug administration targeting Onchocerca volvulus in Owabi catchment area in Ashanti Region, Ghana : Determinants of drug coverage and drug uptake. / Osei, Francis Adjei; Newton, Sam; Nyanor, Isaac; Osei-Yeboah, Eugene; Amuzu, Evans Xorse; Mensah, Nicholas Karikari; Nyarko, Obed Ofori; Amanor, Ernest; Boadi, Stephanie; Asare, Ophebia; Odoom, Samuel Frimpong; Furu, Peter; Owusu-Dabo, Ellis; Meyrowitsch, Dan Wolf.
In: Parasite Epidemiology and Control, Vol. 16, e00235, 02.2022.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Mass drug administration targeting Onchocerca volvulus in Owabi catchment area in Ashanti Region, Ghana
T2 - Determinants of drug coverage and drug uptake.
AU - Osei, Francis Adjei
AU - Newton, Sam
AU - Nyanor, Isaac
AU - Osei-Yeboah, Eugene
AU - Amuzu, Evans Xorse
AU - Mensah, Nicholas Karikari
AU - Nyarko, Obed Ofori
AU - Amanor, Ernest
AU - Boadi, Stephanie
AU - Asare, Ophebia
AU - Odoom, Samuel Frimpong
AU - Furu, Peter
AU - Owusu-Dabo, Ellis
AU - Meyrowitsch, Dan Wolf
N1 - Funding Information: The work was funded by DANIDA under the Building Stronger Universities (BSU) - Work Package III (Health Delivery System) issued by the KNUST Office of Grants and Research through the KNUST College of Health Sciences. Publisher Copyright: © 2021
PY - 2022/2
Y1 - 2022/2
N2 - Introduction: Achieving high Mass Drug Administration (MDA) coverage and drug uptake are pivotal in the efforts to eradicate onchocerciasis. The present study investigated the extent and predictors of ivermectin MDA coverage and uptake from the individual and healthcare providers' perspectives. The extent of ivermectin distribution and uptake, and the predictors of distribution and uptake were investigated in endemic communities in the Ashanti Region of Ghana. Methods: A cross-sectional survey was conducted from August to October 2019 in communities within the Atwima Nwabiagya North District. A total of 2008 respondents were interviewed. Data was collected with REDCap mobile App which had an electronic version of the structured questionnaire. Descriptive data was presented in frequency tables, and bivariate and multivariate logistics regression analysis were performed to measure the associations between exposure variables and outcome variables which were received and uptake of MDA drugs. Results: A total of 1284 (63.9%) respondents did not receive ivermectin during the 2019 MDA programme and more than half of them were not aware of the drug distribution (53.3%). The most common reasons for not ingesting the drug were fear of side effects (47.7%) and not trusting the drug distributors (20.0%). Respondents in the age group 48–57 years (AOR = 1.37; 95%CI: 1.01–2.67), Persons in the high wealth index (AOR = 1.40; 95%CI: 1.11–1.77), Being aware of the MDA programme (AOR = 6.67: 95%CI: 4.76–9.35), MDA being beneficial (AOR = 2.12; 95%CI: 1.54–2.92) participating in previous MDA (AOR = 5.44; 95%CI: 4.25–6.98) and having stayed in the communities for 10 years and above significantly increased the odds of receiving MDA drugs. Previous uptake of MDA drugs (AOR = 10.58; 95%CI: 5.78–19.38) and perception of the MDA drug as beneficial (AOR = 5.25; 95%CI: 2.55–10.82) increased the likelihood of ingesting drugs when received. Conclusion: The main health system challenge was limited awareness creation regarding MDA. This seems to affect the optimal utilization of the ivermectin MDA intervention. MDA programmes against onchocerciasis eradication should be designed taking into account specific contextual factors to improve implementation outcomes.
AB - Introduction: Achieving high Mass Drug Administration (MDA) coverage and drug uptake are pivotal in the efforts to eradicate onchocerciasis. The present study investigated the extent and predictors of ivermectin MDA coverage and uptake from the individual and healthcare providers' perspectives. The extent of ivermectin distribution and uptake, and the predictors of distribution and uptake were investigated in endemic communities in the Ashanti Region of Ghana. Methods: A cross-sectional survey was conducted from August to October 2019 in communities within the Atwima Nwabiagya North District. A total of 2008 respondents were interviewed. Data was collected with REDCap mobile App which had an electronic version of the structured questionnaire. Descriptive data was presented in frequency tables, and bivariate and multivariate logistics regression analysis were performed to measure the associations between exposure variables and outcome variables which were received and uptake of MDA drugs. Results: A total of 1284 (63.9%) respondents did not receive ivermectin during the 2019 MDA programme and more than half of them were not aware of the drug distribution (53.3%). The most common reasons for not ingesting the drug were fear of side effects (47.7%) and not trusting the drug distributors (20.0%). Respondents in the age group 48–57 years (AOR = 1.37; 95%CI: 1.01–2.67), Persons in the high wealth index (AOR = 1.40; 95%CI: 1.11–1.77), Being aware of the MDA programme (AOR = 6.67: 95%CI: 4.76–9.35), MDA being beneficial (AOR = 2.12; 95%CI: 1.54–2.92) participating in previous MDA (AOR = 5.44; 95%CI: 4.25–6.98) and having stayed in the communities for 10 years and above significantly increased the odds of receiving MDA drugs. Previous uptake of MDA drugs (AOR = 10.58; 95%CI: 5.78–19.38) and perception of the MDA drug as beneficial (AOR = 5.25; 95%CI: 2.55–10.82) increased the likelihood of ingesting drugs when received. Conclusion: The main health system challenge was limited awareness creation regarding MDA. This seems to affect the optimal utilization of the ivermectin MDA intervention. MDA programmes against onchocerciasis eradication should be designed taking into account specific contextual factors to improve implementation outcomes.
KW - Ghana
KW - Ivermectin
KW - Mass drug administration
KW - Onchocerciasis
U2 - 10.1016/j.parepi.2021.e00235
DO - 10.1016/j.parepi.2021.e00235
M3 - Journal article
C2 - 35024476
AN - SCOPUS:85122060735
VL - 16
JO - Parasite Epidemiology and Control
JF - Parasite Epidemiology and Control
SN - 2405-6731
M1 - e00235
ER -
ID: 289157773